New Releases from NCBI BookshelfCabotegravir for preventing HIV-1 in adults and young people.Cabotegravir for preventing HIV-1 in adults and young people.
Post Content
Uncategorized
New Releases from NCBI BookshelfTofacitinib: Reimbursement Recommendation [Internet].Tofacitinib: Reimbursement Recommendation [Internet].
The Formulary Management Expert Committee (FMEC) recommends that tofacitinib be reimbursed for the treatment of patients with juvenile idiopathic arthritis
Uncategorized
New Releases from NCBI BookshelfGuideline for the prevention, diagnosis and treatment of infertility [Internet].Guideline for the prevention, diagnosis and treatment of infertility [Internet].
The objective of this guideline is to provide evidence-based recommendations to prevent, diagnose and treat infertility. It provides a source
Uncategorized
New Releases from NCBI BookshelfTreatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal.Treatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal.
The National Institute for Health and Care Excellence is piloting a new approach to evaluating health technologies, which takes into
Uncategorized
New Releases from NCBI BookshelfLearning together to promote mental health and well-being in English secondary schools: LTMH study refinement and feasibility evaluation, a comprehensive synopsis.Learning together to promote mental health and well-being in English secondary schools: LTMH study refinement and feasibility evaluation, a comprehensive synopsis.
Young people’s mental health worsened during and since the coronavirus disease discovered in 2019 pandemic. School environments play a key
Uncategorized
New Releases from NCBI BookshelfReducing self-harm in adolescents: the RISA-IPD comprehensive synopsis.Reducing self-harm in adolescents: the RISA-IPD comprehensive synopsis.
Self-harm is common in adolescents and a major public health concern. Evidence for effective interventions is lacking. An individual participant
Uncategorized
New Releases from NCBI BookshelfHome-based extended rehabilitation for older people with frailty (HERO): a multicentre randomised controlled trial with health economic analysis and process evaluation.Home-based extended rehabilitation for older people with frailty (HERO): a multicentre randomised controlled trial with health economic analysis and process evaluation.
Half of older people in hospital have frailty and are at increased risk of re-admission or death following discharge. Although
